New drug duo tested in fight against stubborn leukemia
NCT ID NCT06382168
Summary
This early-stage study is testing whether combining an experimental drug (DFP-10917) with an approved drug (venetoclax) is safe and effective for adults with acute myeloid leukemia (AML) that has come back or not responded to previous treatments. The first part of the study aims to find the safest dose, and the second part will see how well the combination works against the leukemia. The trial is enrolling up to 39 participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEUKEMIA, MYELOID, ACUTE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Atrium Health Wake Forest Baptist Comprehensive Cancer Center
RECRUITINGWinston-Salem, North Carolina, 27157, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
UCI Chao Family Comprehensive Cancer Center
RECRUITINGOrange, California, 92868, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University of Vermont Cancer Center
RECRUITINGBurlington, Vermont, 05401, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Virginia Cancer Center
RECRUITINGCharlottesville, Virginia, 22911, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.